SCHEMBL1301667

SCHEMBL1301667

CC(=O)OC(C)CCC=C(C)C

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 4/20 0.55
TSHR P16473 3/20 0.46
ALDH1A1 P00352 3/20 0.45
CHRM2 P08172 1/20 0.45
CHRM4 P08173 1/20 0.45
CHRM1 P11229 1/20 0.45
TBXA2R P21731 1/20 0.45
GALR3 O60755 1/20 0.44
MAPT P10636 1/20 0.44
BLM P54132 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
USP2 O75604 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30464014 1.00 ALOX15 (0.55) ALOX15TSHRALDH1A1CHRM2CHRM4
SCHEMBL12215438 0.89 ALOX15 (0.53) ALOX15ALDH1A1MAPT
SCHEMBL14826010 0.89 ALOX15 (0.53) ALOX15ALDH1A1MAPT
SCHEMBL14815406 0.89 ALOX15 (0.53) ALOX15ALDH1A1MAPT
SCHEMBL1171362 0.89 ALOX15 (0.53) ALOX15ALDH1A1MAPT
SCHEMBL1302069 0.89 ALOX15 (0.53) ALOX15ALDH1A1MAPT
SCHEMBL12215439 0.89 ALOX15 (0.53) ALOX15ALDH1A1MAPT
SCHEMBL1171361 0.89 ALOX15 (0.53) ALOX15ALDH1A1MAPT
SCHEMBL18076324 0.89 ALOX15 (0.53) ALOX15ALDH1A1MAPT
SCHEMBL1617388 0.85 ALOX15 (0.57) ALOX15TSHRALDH1A1CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240277012-A1 DUPLICATE BEVERAGE WANG JIE (US) 2024-08-22 US disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
EP-3416729-B1 PRO-FRAGRANCE COMPOSITION AQDOT LTD (GB) 2023-09-20 EP disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 EP disclosed
CN-108601958-B Pro-fragrance compositions 爱客多有限公司 2022-06-17 CN disclosed
US-11357246-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2022-06-14 US disclosed
US-20210227863-A1 HIGH INTENSITY SWEETENERS SENOMYX, INC. 2021-07-29 US disclosed
CN-108473484-B Compounds useful as TRPM8 modulators 弗门尼舍公司 2021-06-29 CN disclosed
EP-3356356-B1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2021-05-26 EP disclosed
US-20170087199-A1 COMPOSITIONS FOR DELIVERING A COOLING SENSATION SENOMYX INC (US) 2017-03-30 US disclosed
US-20160376263-A1 BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF SENOMYX INC (US) 2016-12-29 US disclosed
US-20110266361-A1 PHEROMONE DISPENSER BASF SE (DE) 2011-11-03 US disclosed
US-5585252-A CATALYTIC ACYLATION OF ALCOHOLS G. D. SEARLE & CO. (US) 1996-12-17 US disclosed
EP-0560408-A1 Enantio- and regioselective syntheses of organic compounds using enol esters as irreversible transacylation reagents G.D. SEARLE & CO. (US) 1993-09-15 EP disclosed
US-5106750-A Enzymatic resolution of hydroxycyclopentenones using lipase G. D. SEARLE & CO. (US) 1992-04-21 US disclosed
EP-0357009-A2 Method of resolution of hydroxy-cyclopentenones using a lipase and transacylation agents G.D. Searle & Co. (US) 1990-03-07 EP disclosed
EP-0131254-B1 PROCESS FOR THE PREPARATION OF SUBSTITUTED TETRAHYDROFURANES L. GIVAUDAN & CIE Société Anonyme (CH) 1988-05-25 EP disclosed
US-4560811-A LEWIS ACID CATALYST, CHIRAL GLYCOL, PEROXY COMPOUNDS, OLEFINS OREPOXZIDES; INTERMEDIATES FOR DRUGS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1985-12-24 US disclosed
EP-0131254-A2 Process for the preparation of substituted tetrahydrofuranes L. GIVAUDAN & CIE Société Anonyme (CH) 1985-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 ALOX15 3088/4885TSHR 3246/4885ALDH1A1 978/4885
US-20160376263-A1 BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF TAS2R5, TAS1R1, TAS2R1 ALOX15 2698/4885TSHR 2120/4885ALDH1A1 1490/4885
US-11357246-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 ALOX15 3088/4885TSHR 3246/4885ALDH1A1 978/4885
US-20170087199-A1 COMPOSITIONS FOR DELIVERING A COOLING SENSATION TRPA1, PDE6G, PDE6D ALOX15 1520/4885TSHR 2063/4885ALDH1A1 1029/4885
US-20210227863-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 ALOX15 3088/4885TSHR 3246/4885ALDH1A1 978/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 ALOX15 3088/4885TSHR 3246/4885ALDH1A1 978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.